The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tumova M.A.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Muslimova L.M.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Stanovaya V.V.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Abdyrakhmanova A.K.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Ivanov M.V.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Contemporary methods of non-drug therapy for depression

Authors:

Tumova M.A., Muslimova L.M., Stanovaya V.V., Abdyrakhmanova A.K., Ivanov M.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(5‑2): 91‑98

DOI: 10.17116/jnevro202112105291

Read: 7771 times

Download PDF (RU)
Contact the author
Table of contents

CONTEMPORARY METHODS OF NON-DRUG THERAPY FOR DEPRESSION
CONTEMPORARY METHODS OF NON-DRUG THERAPY FOR DEPRESSION

To cite this article:

Tumova MA, Muslimova LM, Stanovaya VV, Abdyrakhmanova AK, Ivanov MV. Contemporary methods of non-drug therapy for depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(5‑2):91‑98. (In Russ.)
https://doi.org/10.17116/jnevro202112105291

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effe­cts of rhythmic transcranial magnetic stimulation in the treatment of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69
Higher-level ambu­lation diso­rders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11-2):32-38
Comparison of the effe­cts of transcranial magnetic stimulation and mema­ntine on motor apha­sia in ischemic stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):72-77
Transcranial magnetic stimulation in visual snow syndrome and functional diso­rders of visual perception. Russian Journal of Pain. 2025;(1):46-54
Reorganization of the corticospinal tract and thalamocortical projections in children with sequelae of severe traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):56-61
Clinical and instrumental diagnostics of facial neuropathy in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):31-36
Asso­ciation of cortisol levels with psychopathological features of depression and therapeutic response in female patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):45-54
Gut—brain: inte­ractions in health and pathology. Russian Journal of Preventive Medi­cine. 2025;(11):106-112
Abstract:

The review presents information on the most effective current non-drug methods of treatment of depression used in practice. A review of publications in PubMed and PsycINFO and Cochrane Library over the past 10 years was conducted. Non-drug biological therapies demonstrate high efficacy in the reduction of depressive symptoms in patients with recurrent depressive disorder. The use of non-drug therapy does not preclude the continuation of pharmacological therapy. In order to choose an optimal method of treatment, the psychophysical state of a patient, severity of depressive symptoms, response to drug therapy, and possibility of prescribing pharmacological therapy should be taken into account, and the principles of evidence-based medicine should be taken into consideration when making a decision.

Keywords:

treatment-resistant depression
transcranial magnetic stimulation
electroconvulsive therapy
neuromodulatio

Authors:

Tumova M.A.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Muslimova L.M.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Stanovaya V.V.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Abdyrakhmanova A.K.

Bekhterev National Research Medical Centre for Psychiatry and Neurology

Ivanov M.V.

Bekhterev National Medical Research Center for Psychiatry and Neurology

Received:

02.04.2021

Accepted:

27.04.2021

Close metadata

References:

  1. Vos T, Barber RM, Bell B, Bertozzl-Villa A, Blrukov S, Bolliger I, Murray CJL. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: Asystematic analysis for the global burden of disease study 2013. The Lancet. 2015;386(9995):743-800.  https://doi.org/10.1016/S0140-6736(15)60692-4
  2. Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci. 2011;34:1-9.  https://pubmed.ncbi.nlm.nih.gov/21067824/
  3. Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model — are we there yet? Behav Brain Res. 2018;341:79-90.  https://doi.org/10.1016/j.bbr.2017.12.025
  4. Santos MAO, Bezerra LS, Carvalho ARMR, Brainer-Lima AM. Global hippocampal atrophy in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Trends Psychiatry Psychother. 2018;40(4):369-378.  https://doi.10.1590/2237-6089-2017-0130
  5. Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25(3):530-543.  https://doi.org/10.1038/s41380-019-0615-x
  6. Fox ME, Lobo MK. The molecular and cellular mechanisms of depression: a focus on reward circuitry. Mol Psychiatry. 2019;24(12):1798-1815. https://doi.org/10.1038/s41380-019-0415-3
  7. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2(3):145-156.  https://doi.org/10.1016/s1474-4422(03)00321-1
  8. Roth Y, Amir A, Levkovitz Y, Zangen A. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol. 2007;24(1):31-38.  https://doi.org/10.1097/WNP.0b013e31802fa393
  9. Cao X, Deng C, Su X, Guo Y. Response and Remission Rates Following High-Frequency vs. Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Over Right DLPFC for Treating Major Depressive Disorder (MDD): A Meta-Analysis of Randomized, Double-Blind Trials. Front Psychiatry. 2018;9:413. Published 2018 Sep 7.  https://doi.org/10.3389/fpsyt.2018.00413
  10. Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(5):477-489.  https://doi.org/10.4088/JCP.13r08815
  11. Tsukarzi EE, Ilyin SA, Mosolov SN. Comparative study of transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT) in therapy-resistant depressions. Modern Therapy of Mental Diseases. 2015;4:25-33. (In Russ.).
  12. Horvath JC, Mathews J, Demitrack MA, Pascual-Leone A. The NeuroStar TMS device: conducting the FDA approved protocol for treatment of depression. J Vis Exp. 2010;45:2345. https://doi.org/10.3791/2345
  13. Papadimitropoulou K, Vossen C, Karabis A, Donatti C, Kubitz N. Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Curr Med Res Opin. 2017;33(4):701-711.  https://doi.org/10.1080/03007995.2016.1277201
  14. Ilyin SA, Tsukarzi EE, Mosolov SN. Comparative efficacy and tolerability of transcranial magnetic stimulation and ECT in patients with protracted depressions resistant to medication. Social and Clinical Psychiatry. 2008;2:73-80. (In Russ.).
  15. Nelson AI. Electroconvulsive therapy in psychiatry, narcology and neurology. M.: BINOM. Laboratory of Knowledge; 2005. (In Russ.).
  16. Pougovkina OD, Kholmogorova AB, Tsukarzi EE, Ilyin SA, Mosolov SN. Dynamics of cognitive functioning in patient with resistant depression treated with ECT and the cyclical Transcranial Magnetic Stimulation (CTMS). Social and Clinical Psychiatry. 2006;2(16):47-51. (In Russ.).
  17. Ban TA. Comment on: ‘antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence’. Int J Neuropsychopharmacol. 2008;11(4):583-589.  https://doi.org/10.1017/S1461145708008729
  18. Mutz J, Edgcumbe DR, Brunoni AR, Fu CHY. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev. 2018;92:291-303.  https://doi.org/10.1016/j.neubiorev.2018.05.015
  19. Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010;40(11):1789-1795. https://doi.org/10.1017/S003329171000005X
  20. Chen J, Zhou C, Wu B, Wang Y, Li Q, Wei Y, Yang D, Mu J, Zhu D, Zou D, Xie P, Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 2013;210:1260-1264. https://doi.org/10.1016/j.psychres.2013.09.007
  21. Kaur M, Michael JA, Fitzgibbon BM, Hoy KE, Fitzgerald PB. Low-frequency rTMS is better tolerated than high-frequency rTMS in healthy people: Empirical evidence from a single session study. J Psychiatr Res. 2019;113:79-82.  https://doi.org/10.1016/j.jpsychires.2019.03.015
  22. Filipčić I, Šimunović Filipčić I, Milovac Ž, et al. Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial. J Psychiatr Res. 2019;114:113-119.  https://doi.org/10.1016/j.jpsychires.2019.04.020
  23. Levkovitz Y, Sheer A, Harel EV, et al. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul. 2011;4(4):266-274.  https://doi.org/10.1016/j.brs.2010.12.004
  24. Ivanov MV, Zubov DS. Pathogenetic aspects of electroconvulsive therapy: hypothesis and evidence. SPB. Russian Psychiatric Journal. 2014;1:57-60. (In Russ.).
  25. Loiseau A, Harrisson MC, Beaudry V, Patry S. Electroconvulsive Therapy Use in Youth in the Province of Quebec. J Can Acad Child Adolesc Psychiatry. 2017;26(1):4-11. 
  26. Sheifer MS, Kryukov SB, Moroz VV, Nosenko NF. Use of ECT in mental disorders resultant to pharmacotherapy. Samara, Social and Clinical Psychiatry. 2008;3:49-52. (In Russ.).
  27. Tsoukalas I. How does ECT work? A new explanatory model and suggestions for non-convulsive applications. Med Hypotheses. 2020;145:110337. https://doi.org/10.1016/j.mehy.2020.110337
  28. Haskett RF. Electroconvulsive therapy’s mechanism of action: neuroendocrine hypotheses. J ECT. 2014;30(2):107-110.  https://doi.org/10.1097/YCT.0000000000000143
  29. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging, 2nd ed. Washington, DC: American Psychiatric Press. 2001;135-157.  https://doi.org/10.1176/appi.ajp.159.2.331
  30. Kolar D. Current status of electroconvulsive therapy for mood disorders: a clinical review. Evid Based Ment Health. 2017;20(1):12-14.  https://doi.org/10.1136/eb-2016-102498
  31. Giacobbe P, Rakita U, Penner-Goeke K, et al. Improvements in Health-Related Quality of Life With Electroconvulsive Therapy: A Meta-analysis. J ECT. 2018;34(2):87-94.  https://doi.org/10.1097/YCT.0000000000000486
  32. Golenkov A, Ungvari GS, Gazdag G. ECT practice and psychiatrists’ attitudes towards ECT in the Chuvash Republic of the Russian Federation. Eur Psychiatry. 2010;25(2):126-128.  https://doi.org/10.1016/j.eurpsy.2009.02.011
  33. Ivanov MV, Zubov DS. Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2019;119(3):92-97. (In Russ.). https://doi.org/10.17116/jnevro201911903192
  34. Li X, Meng H, Fu Y, et al. The Impact of Whole Brain Global Functional Connectivity Density Following MECT in Major Depression: A Follow-Up Study. Front Psychiatry. 2019;10:7. Published 2019 Mar 1.  https://pubmed.ncbi.nlm.nih.gov/30890964
  35. Enneking V, Leehr EJ, Dannlowski U, Redlich R. Brain structural effects of treatments for depression and biomarkers of response: a systematic review of neuroimaging studies. Psychol Med. 2020;50(2):187-209.  https://doi.org/10.1017/S0033291719003660
  36. Levy A, Taib S, Arbus C, et al. Neuroimaging Biomarkers at Baseline Predict Electroconvulsive Therapy Overall Clinical Response in Depression: A Systematic Review. J ECT. 2019;35(2):77-83.  https://doi.org/10.1097/YCT.0000000000000570
  37. Gazdag G, Ungvari GS. Electroconvulsive therapy: 80 years old and still going strong. World J Psychiatr. 2019;9(1):1-6.  https://pubmed.ncbi.nlm.nih.gov/30631748/
  38. Fink M, Kellner CH, McCall WV. The role of ECT in suicide prevention. JECT. 2014;30(1):5-9.  https://doi.org/10.1097/YCT.0b013e3182a6ad0d
  39. Klysner R, Bjerg Bendsen B, Hansen MS. Transient serotonin toxicity evoked by combination of electroconvulsive therapy and fluoxetine. Case Rep Psychiatry. 2014;2014:162502. https://doi.org/10.1155/2014/162502
  40. Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA. 2007;298(3):330-332.  https://doi.org/10.1001/jama.298.3.330
  41. Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 2016;12:931-939.  https://doi.org/10.2147/NDT.S100908
  42. Vovin RYa, Aksenova IO. Prolonged depressive states. L.: Medicine; 1982. (In Russ.).
  43. Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38(12):2467-2474. https://doi.org/10.1038/npp.2013.149
  44. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive- compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525-549.  https://doi.org/10.1016/j.neubiorev.2007.09.005
  45. Marchand WR. Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disorders. Brain Struct Funct. 2010;215(2):73-96.  https://doi.org/10.1007/s00429-010-0280-y
  46. Furman DJ, Hamilton JP, Gotlib IH. Frontostriatal functional connectivity in major depressive disorder. Biol Mood Anxiety Disord. 2011;1(1):11. Published 2011 Dec 8.  https://doi.org/10.1186/2045-5380-1-11
  47. Kopell BH, Greenberg B, Rezai AR. Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol off Publ Am Electroencephalogr Soc. 2004;21(1):51-67.  https://doi.org/10.1097/00004691-200401000-00007
  48. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry. 2004;61(8):765-773.  https://doi.org/10.1001/archpsyc.61.8.765
  49. Lopes AC, de Mathis ME, Canteras MM, Salvajoli JV, Del Porto JA, Miguel EC. Atualização sobre o tratamento neurocirúrgico do transtorno obsessivo-compulsivo [Update on neurosurgical treatment for obsessive compulsive disorder]. Braz J Psychiatry. 2004;26(1):62-66.  https://doi.org/10.1590/S1516-44462004000100015
  50. Kholyavin AI Anichkov AD. Guidance methods in modern stereotaxic neurosurgery. M.: Russian Academy of Sciences; 2017. (In Russ.).
  51. Dandekar MP, Fenoy AJ, Carvalho AF, Soares JC, Quevedo J. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications. Mol Psychiatry. 2018;23:1094-1112. https://doi.org/10.1038/mp.2018.2
  52. Korzenev AV, Abritalin EY. Disorders resistance overcoming via vagus nerve stimulation and deep brain stimulatio. Bulletin of the SB RAMS. 2010;30(5):30-34. (In Russ.).
  53. Lozano, Andres M, et al. Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression. Biological Psychiatry. 2005;64(6):461-467.  https://doi.org/10.1016/j.biopsych.2008.05.034
  54. Bergfeld IO, Mantione M, Hoogendoorn MLC, Ruhe HG, Notten P, van Laarhoven J, Visser I, Figee M, de Kwaasteniet BP, Horst F, et al. Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2016;73:456-464.  https://doi.org/10.1001/jamapsychiatry.2016.0152
  55. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33:368-377.  https://doi.org/10.1038/sj.npp.1301408
  56. Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O’Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, et al. A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression. Biol Psychiatry. 2015;78:240-248.  https://doi.org/10.1016/j.biopsych.2014.11.023
  57. Raymaekers S, Luyten L, Bervoets C, Gabriels L, Nuttin B. Deep brain stimulation for treatment-resistant major depressive disorder: A comparison of two targets and long-term follow-up. Transl Psychiatry. 2017;7:e1251. https://doi.org/10.1038/tp.2017.66
  58. Fenoy AJ, Schulz PE, Selvaraj S, Burrows CL, Zunta-Soares G, Durkin K, et al. A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression. Transl Psychiatry. 2018;8:111.  https://doi.org/10.1038/s41398-018-0160-4
  59. Sartorius A, Kiening KL, Kirsch P, von Gall CC, Haberkorn U, Unterberg AW, Henn FA, Meyer-Lindenberg A. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry. 2010;67:9-11.  https://doi.org/10.1016/j.biopsych.2009.08.027
  60. Kisely S, Li A, Warren N, Siskind D. A systematic review and meta-analysis of deep brain stimulation for depression. Depress Anxiety. 2018;35:468-480.  https://doi.org/10.1002/da.22746
  61. Berlim MT, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P. Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: A systematic review and exploratory meta-analysis. J Affect Disord. 2014;159:31-38.  https://doi.org/10.1016/j.jad.2014.02.016
  62. Zhou C, Zhang H, Qin Y, Tian T, Xu B, Chen J, Zhou X, Zeng L, Fang L, Qi X, et al. A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018;82:224-232.  https://doi.org/10.1016/j.pnpbp.2017.11.012
  63. Hitti FL, Yang AI, Cristancho MA, Baltuch GH. Deep Brain Stimulation Is Effective for Treatment-Resistant Depression: A Meta-Analysis and Meta-Regression. J Clin Med. 2020;9(9):2796. Published 2020 Aug 30.  https://doi.org/10.3390/jcm9092796
  64. Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017;23:28-38.  https://doi.org/10.1038/nm.4246
  65. Jiménez F, Velasco F, Salín-Pascual R, Velasco M, Nicolini H, Velasco AL, Castro G. Neuromodulation of the inferior thalamic peduncle for major depression and obsessive-compulsive disorder. Acta Neurochir Suppl. 2007;97(2):393-398.  https://doi.org/10.1007/978-3-211-33081-4_44
  66. Lozano, Andres M, et al. Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression. Biological Psychiatry. 2005;64(6):461-467.  https://doi.org/10.1016/j.biopsych.2008.05.034
  67. Eitan R, Lerer B. Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci. 2006;8(2):241-258.  https://doi.org/10.31887/DCNS.2006.8.2/reitan
  68. Müller HHO, Moeller S, Lücke C, Lam AP, Braun N, Philipsen A. Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use. Front Neurosci. 2018;12:239. Published 2018 Apr 10.  https://doi.org/10.3389/fnins.2018.00239
  69. Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl). 2013;6:17‐35.  https://doi.org/10.2147/MDER.S41017
  70. Tisi G, Franzini A, Messina G, Savino M, Gambini O. Vagus nerve stimulation therapy in treatment-resistant depression: a series report. Psychiatry Clin Neurosci. 2014;68(8):606-611.  https://doi.org/10.1111/pcn.12166
  71. Bottomley JM, LeReun C, Diamantopoulos A, Mitchell S, Gaynes BN. Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: A systematic review and meta-analysis [published online ahead of print, 2019 Dec 12]. Compr Psychiatry. 2019;98:152156. https://doi.org/10.1016/j.comppsych.2019.152156
  72. Dibué-Adjei M, Kamp MA, Vogelsang J, Wiltfang J, Wolff-Menzler C. Vagusnervstimulation bei affektiven Störungen [Vagus Nerve Stimulation for Affective Disorders]. Fortschr Neurol Psychiatr. 2020;88(1):40-51.  https://doi.org/10.1055/a-1003-6678
  73. Schneider UC, Bohlmann K, Vajkoczy P, Straub HB. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy generator, AspireSR: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system. Acta Neurochir (Wien). 2015;157(4):721-728.  https://doi.org/10.1007/s00701-015-2362-3
  74. Brown LT, Mikell CB, Youngerman BE, et al. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies. J Neurosurg. 2016;124:77-89.  https://doi.org/10.3171/2015.1.JNS14681
  75. Morita T, Tanabe HC, Sasaki AT, Shimada K, Kakigi R, Sadato N. The anterior insular and anterior cingulate cortices in emotional processing for self-face recognition. Soc Cogn Affect Neurosci. 2014;9(5):570-579.  https://doi.org/10.1093/scan/nst011
  76. Shenhav A, Botvinick MM, Cohen JD. The expected value of control: an integrative theory of anterior cingulate cortex function. Neuron. 2013;79(2):217-240.  https://doi.org/10.1016/j.neuron.2013.07.007
  77. Spangler WJ, Cosgrove GR, Ballantine HT Jr, Cassem EH, Rauch SL, Nierenberg A, Price BH. Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery. 1996;38(6):1071-1076; discussion 1076-8. PMID: 8727135.
  78. Donald C. Shields, et al. Prospective Assessment of Stereotactic Ablative Surgery for Intractable Major Depression. Biological Psychiatry. 2008;64(6):449-454.  https://doi.org/10.1016/j.biopsych.2008.04.009
  79. Martínez-Álvarez R. Radiosurgery for Behavioral Disorders. Prog Neurol Surg. 2019;34:289-297.  https://doi.org/10.1159/000493076
  80. Shustin VA, Vovin RYa, Korzenev AV. Surgical correction of some psychopathological disorders. Edited by Kabanova M.M. SPB., Ed. St. Petersburg Scientific Research Psychoneurological Institute. V.M. Bekhterev. 1997;136:123. (In Russ).
  81. Sheth SA, Neal J, Tangherlini F, Mian MK, Gentil A, Cosgrove GR, et al. Limbic system surgery for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients. J Neurosurg. 2013;118(3):491-497.  https://doi.org/10.3171/2012.11.JNS12389
  82. Baer L, Rauch SL, Ballantine HT, Martuza R, Cosgrove R, Cassem E, et al. Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry. 1995;52(5):384-392.  https://doi.org/10.1001/archpsyc.1995.03950170058008
  83. Mashour GA, Walker EE, Martuza RL. Psychosurgery: past, present, and future. Brain Res Brain Res Rev. 2005;48(3):409-419.  https://doi.org/10.1016/j.brainresrev.2004.09.002
  84. Gasquoine PG. Localization of function in anterior cingulate cortex: from psychosurgery to functional neuroimaging. Neurosci Biobehav Rev. 2013;37(3):340-348.  https://doi.org/10.1016/j.neubiorev.2013.01.002
  85. Christmas D, Eljamel MS, Butler S, Hazari H, MacVicar R, Steele JD, Livingstone A, Matthews K. Long term outcome of thermal anterior capsulotomy for chronic, treatment refractory depression. J Neurol Neurosurg Psychiatry. 2011;82(6):594-600.  https://doi.org/10.1136/jnnp.2010.217901
  86. Hurwitz TA, Honey CR, Allen J, Gosselin C, Hewko R, Martzke J, Bogod N, Taylor P. Bilateral anterior capsulotomy for intractable depression. J Neuropsychiatry Clin Neurosci. 2012;24(2):176-182.  https://doi.org/10.1176/appi.neuropsych.11080189
  87. Knight G. Further observations from an experience of 660 cases of stereotactic tractotomy. Postgrad Med J. 1973;49:845-854.  https://doi.org/10.1136/pgmj.49.578.845
  88. Park SC, Lee JK, Kim CH, Hong JP, Lee DH. Gamma-knife subcaudate tractotomy for treatment-resistant depression and target characteristics: a case report and review. Acta Neurochir (Wien). 2017;159(1):113-120.  https://doi.org/10.1007/s00701-016-3001-3
  89. Moon-Chan KIM, Tae-Kyu LEE, Chang-Rak CHOI, Review of Long-term Results of Stereotactic Psychosurgery. Neurologia Medico-Chirurgica. 2002;365-371.  https://doi.org/10.2176/nmc.42.365
  90. Coenen VA, Honey CR. Ablative procedures for depression. In: Lozano AM, Gildenberg PL, Tasker RR, editors. Textbook of stereotactic and functional neurosurgery. Berlin, Heidelberg: Springer; 2009.
  91. Kelly D, Mitchell-Heggs N. Stereotactic limbic leucotomy — a follow-up study of thirty patients. Postgrad Med J. 1973;49(578):865-882.  https://doi.org/10.1136/pgmj.49.578.865
  92. Montoya A, Weiss AP, Price BH, et al. Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery. 2002;50(5):1043-1052. https://doi.org/10.1097/00006123-200205000-00018
  93. Mitchell-Heggs N, Kelly D, Richardson A: Stereotactic limbic leucotomy — a follow-up at 16 months. Br J Psychiatry. 1976;128:226-240.  https://doi.org/10.1192/bjp.128.3.226
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.